$NXGL
NEXGEL, INC. Stock $nxgl

$nxgl Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223009190 Filed on March 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$620.0K	$524.0K	$2.048M
YoY Change	56.57%	-1.69%	32.04%
Cost Of Revenue	$677.0K	$488.0K	$1.792M
YoY Change	61.96%	13.75%	16.21%
Gross Profit	-$57.00K	$36.00K	$256.0K
YoY Change	159.09%	-65.38%	2744.44%
Gross Profit Margin	-9.19%	6.87%	12.5%
Selling, General & Admin	$797.0K	$778.0K	$3.237M
YoY Change	4.05%	-18.96%	27.04%
% of Gross Profit		2161.11%	1264.45%
Research & Development	$29.00K	$39.00K	$367.0K
YoY Change	20.83%	25.81%	1083.87%
% of Gross Profit		108.33%	143.36%
Depreciation & Amortization	$31.00K	$28.00K	$112.0K
YoY Change	10.71%	-130.11%	-0.88%
% of Gross Profit		77.78%	43.75%
Operating Expenses	$826.0K	$817.0K	$3.604M
YoY Change	4.56%	-17.56%	39.74%
Operating Profit	-$883.0K	-$781.0K	-$3.348M
YoY Change	8.74%	-11.95%	30.27%
Interest Expense	$72.00K	$75.00K	-$1.251M
YoY Change	-108.24%	-108.52%	-37.14%
% of Operating Profit
Other Income/Expense, Net	$76.00K	$60.00K	-$1.398M
YoY Change	-107.42%		-19.66%
Pretax Income	-$807.0K	-$648.0K	-$4.746M
YoY Change	-56.05%	-60.46%	10.12%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$814.0K	-$648.0K	-$4.700M
YoY Change	-55.66%	-60.46%	9.05%
Net Earnings / Revenue	-131.29%	-123.66%	-229.49%
Basic Earnings Per Share	-$0.15		-$0.85
Diluted Earnings Per Share	-$0.15	-$0.12	-$0.85
COMMON SHARES
Basic Shares Outstanding	5.611M shares		5.575M shares
Diluted Shares Outstanding	5.586B shares		5.575M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.803M	$6.609M	$6.609M
YoY Change	-44.84%	-50.49%	-50.49%
Cash & Equivalents	$787.0K	$1.101M
Short-Term Investments	$5.016M	$5.508M	$5.508M
Other Short-Term Assets	$129.0K	$172.0K	$172.0K
YoY Change	-22.75%	123.38%	123.38%
Inventory	$968.0K	$502.0K	$502.0K
Prepaid Expenses
Receivables	$380.0K	$222.0K	$222.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.280M	$7.505M	$7.505M
YoY Change	-34.41%	-46.11%	-46.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.282M	$721.0K	$2.458M
YoY Change	83.67%	-0.28%	-7.21%
Goodwill	$311.0K	$311.0K
YoY Change	0.0%	0.0%
Intangibles	$16.00K	$20.00K
YoY Change	-46.67%	-39.39%
Long-Term Investments
YoY Change
Other Assets	$95.00K	$63.00K	$63.00K
YoY Change	50.79%	0.0%	0.0%
Total Long-Term Assets	$3.726M	$2.852M	$2.852M
YoY Change	24.99%	-6.68%	-6.68%
TOTAL ASSETS
Total Short-Term Assets	$7.280M	$7.505M	$7.505M
Total Long-Term Assets	$3.726M	$2.852M	$2.852M
Total Assets	$11.01M	$10.36M	$10.36M
YoY Change	-21.83%	-39.02%	-39.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$987.0K	$265.0K	$265.0K
YoY Change	439.34%	4.33%	4.33%
Accrued Expenses	$328.0K	$337.0K	$337.0K
YoY Change	24.24%	25.28%	25.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$15.00K	$15.00K	$15.00K
YoY Change	7.14%	50.0%	50.0%
Total Short-Term Liabilities	$1.522M	$859.0K	$859.0K
YoY Change	-15.63%	-70.26%	-70.26%
LONG-TERM LIABILITIES
Long-Term Debt	$266.0K	$268.0K	$268.0K
YoY Change	0.38%	0.75%	0.75%
Other Long-Term Liabilities	$1.864M	$1.593M	$1.593M
YoY Change	9.2%	-8.66%	-8.66%
Total Long-Term Liabilities	$2.130M	$1.861M	$1.861M
YoY Change	8.01%	-7.41%	-7.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.522M	$859.0K	$859.0K
Total Long-Term Liabilities	$2.130M	$1.861M	$1.861M
Total Liabilities	$3.652M	$2.720M	$2.720M
YoY Change	-3.28%	-44.47%	-44.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.37M	-$11.56M
YoY Change	43.06%	69.67%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.847M	$7.637M	$7.637M
YoY Change
Total Liabilities & Shareholders Equity	$11.01M	$10.36M	$10.36M
YoY Change	-21.83%	-39.02%	-39.02%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$814.0K	-$648.0K	-$4.700M
YoY Change	-55.66%	-60.46%	9.05%
Depreciation, Depletion And Amortization	$31.00K	$28.00K	$112.0K
YoY Change	10.71%	-130.11%	-0.88%
Cash From Operating Activities	-$709.0K	-$649.0K	-$3.000M
YoY Change	-11.38%	-45.78%	9.09%
INVESTING ACTIVITIES
Capital Expenditures	$88.00K	$8.000K	$96.00K
YoY Change		-93.39%	-64.31%
Acquisitions	$500.0K
YoY Change
Other Investing Activities	$485.0K	$481.0K	-$5.499M
YoY Change
Cash From Investing Activities	$397.0K	$473.0K	-$5.595M
YoY Change		290.91%	1979.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.000K	-150.0K	-$3.662M
YoY Change	-99.9%	-101.14%	-122.41%
NET CHANGE
Cash From Operating Activities	-$709.0K	-649.0K	-$3.000M
Cash From Investing Activities	$397.0K	473.0K	-$5.595M
Cash From Financing Activities	-$2.000K	-150.0K	-$3.662M
Net Change In Cash	-$314.0K	-326.0K	-$12.26M
YoY Change	-88.92%	-102.7%	-192.01%
FREE CASH FLOW
Cash From Operating Activities	-$709.0K	-$649.0K	-$3.000M
Capital Expenditures	$88.00K	$8.000K	$96.00K
Free Cash Flow	-$797.0K	-$657.0K	-$3.096M
YoY Change	-0.38%	-50.15%	2.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001468929
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	NXGL	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt		usd
CY2022	NXGL	Debt Financing Costs DebtFinancingCosts		usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments		usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2021	NXGL	Stock Issued During Period Value Share Adjustment For Stock Split Rounding StockIssuedDuringPeriodValueShareAdjustmentForStockSplitRounding		usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2022	NXGL	Forgiveness Of Debt ForgivenessOfDebt		usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	NXGL	Payment Of Financing Costs PaymentOfFinancingCosts		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	NXGL	Proceeds From Notes Payable Paycheck Protection Program ProceedsFromNotesPayablePaycheckProtectionProgram		usd
CY2022	NXGL	Fair Value Of Beneficial Conversion And Warrant FairValueOfBeneficialConversionAndWarrant		usd
CY2022	NXGL	Original Issue Discounts Recognized On Convertible Notes Payable OriginalIssueDiscountsRecognizedOnConvertibleNotesPayable		usd
CY2022	NXGL	Warrants Issued Equity Issuance Cost WarrantsIssuedEquityIssuanceCost		usd
CY2022	NXGL	Operating Lease Rou Assets And Liabilities OperatingLeaseRouAssetsAndLiabilities		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2021	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled		shares
CY2021	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Cancelled Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2021	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled		shares
CY2022	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Cancelled Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageCancelledPrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2021	us-gaap	Federal State And Local Income Tax Expense Benefit Continuing Operations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41173
CY2022	dei	Entity Registrant Name EntityRegistrantName	NexGel, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-4042544
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2150 Cabot Blvd West
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite B
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Langhorne
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19047
CY2022	dei	City Area Code CityAreaCode	(215)
CY2022	dei	Local Phone Number LocalPhoneNumber	702-8550
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	7524481	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5611282	shares
CY2022	dei	Auditor Firm AuditorFirmId	76
CY2022	dei	Auditor Name AuditorName	Turner, Stone & Company, L.L.P
CY2022	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2022Q4	us-gaap	Cash Cash	1101000	usd
CY2021Q4	us-gaap	Cash Cash	13350000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5508000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	222000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	502000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	291000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	172000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7505000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	13927000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	311000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	311000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	721000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	723000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1737000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1926000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63000	usd
CY2022Q4	us-gaap	Assets Assets	10357000	usd
CY2021Q4	us-gaap	Assets Assets	16983000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	265000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	254000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	130000	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	62000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2037000	usd
CY2022Q4	NXGL	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	15000	usd
CY2021Q4	NXGL	Notes Payable Excluding Convertible Notes Payable Current NotesPayableExcludingConvertibleNotesPayableCurrent	10000	usd
CY2022Q4	NXGL	Warrant Liability Current WarrantLiabilityCurrent	242000	usd
CY2021Q4	NXGL	Warrant Liability Current WarrantLiabilityCurrent	318000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	207000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	859000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2888000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1593000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1744000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	268000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	266000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2720000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4898000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5577916	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5577916	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5572234	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5572234	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19189000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18891000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11558000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6812000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7637000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12085000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10357000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16983000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2048000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1551000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1792000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1543000	usd
CY2022	us-gaap	Gross Profit GrossProfit	256000	usd
CY2021	us-gaap	Gross Profit GrossProfit	8000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	367000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3237000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2547000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3604000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2578000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3348000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2570000	usd
CY2022	NXGL	Change In Fair Value Of Warrant Liability And Warrant Modification Expense ChangeInFairValueOfWarrantLiabilityAndWarrantModificationExpense	-76000	usd
CY2021	NXGL	Change In Fair Value Of Warrant Liability And Warrant Modification Expense ChangeInFairValueOfWarrantLiabilityAndWarrantModificationExpense	-8000	usd
CY2021	NXGL	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	275000	usd
CY2021	NXGL	Debt Financing Costs DebtFinancingCosts	-68000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	9000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-150000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1336000	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1930000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1398000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1740000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4746000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4310000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.45
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5574818	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2979962	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	71000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13471000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	61000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	2587000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	223000	usd
CY2021	NXGL	Adjustment To Additional Paid In Capital Derivative Liability AdjustmentToAdditionalPaidInCapitalDerivativeLiability	-18000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4310000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12085000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12085000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	231000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	67000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4746000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7637000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4746000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-4310000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	112000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	113000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	298000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	285000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	9000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-133000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8000	usd
CY2022	NXGL	Warrant Modification Expense WarrantModificationExpense	57000	usd
CY2021	NXGL	Warrant Modification Expense WarrantModificationExpense	52000	usd
CY2021	NXGL	Forgiveness Of Debt ForgivenessOfDebt	-275000	usd
CY2022	NXGL	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	189000	usd
CY2021	NXGL	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	25000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-150000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1324000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1933000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	137000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	211000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	95000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-63000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-405000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	74000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-18000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-38000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2992000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2753000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	96000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	269000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1500000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6999000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5595000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-269000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	151000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13471000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2957000	usd
CY2021	NXGL	Payment Of Financing Costs PaymentOfFinancingCosts	-115000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3511000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000	usd
CY2021	NXGL	Proceeds From Notes Payable Paycheck Protection Program ProceedsFromNotesPayablePaycheckProtectionProgram	127000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3662000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16340000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12249000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13318000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13350000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1101000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13350000	usd
CY2021	NXGL	Fair Value Of Beneficial Conversion And Warrant FairValueOfBeneficialConversionAndWarrant	2587000	usd
CY2021	NXGL	Original Issue Discounts Recognized On Convertible Notes Payable OriginalIssueDiscountsRecognizedOnConvertibleNotesPayable	653000	usd
CY2021	NXGL	Warrants Issued Equity Issuance Cost WarrantsIssuedEquityIssuanceCost	203000	usd
CY2021	NXGL	Operating Lease Rou Assets And Liabilities OperatingLeaseRouAssetsAndLiabilities	2050000	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-35 reverse stock split
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Cash Cash	1100000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5500000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4700000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3000000.0	usd
CY2022Q4	NXGL	Working Capital Deficit WorkingCapitalDeficit	6600000	usd
CY2021Q4	NXGL	Units Issued During Period Shares New Issues UnitsIssuedDuringPeriodSharesNewIssues	2585000	shares
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.50
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.50
CY2021Q4	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	14200000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zQ5H6DYYPKV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_z5bF9vFUYoi7">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates and assumptions include allowances for doubtful accounts, inventory reserves, deferred taxes, share-based compensation and related valuation allowances and fair value of long-lived assets. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zXVDMj4ZUfR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zSlvVExrdMe">Reclassifications</span> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have reclassified, combined or separately disclosed certain amounts in the prior years’ consolidated financial statements and accompanying footnotes to conform with the current year’s presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	5508000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	295000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	51000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	156000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	178000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	88000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	54000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	63000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	23000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	109000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	5508000	usd
CY2022	NXGL	Revenue From Contract Manufacturing RevenueFromContractManufacturing	1033000	usd
CY2021	NXGL	Revenue From Contract Manufacturing RevenueFromContractManufacturing	767000	usd
CY2022	NXGL	Revenue From Finished Goods RevenueFromFinishedGoods	34000	usd
CY2021	NXGL	Revenue From Finished Goods RevenueFromFinishedGoods	194000	usd
CY2022	NXGL	Revenue From Consumer Products RevenueFromConsumerProducts	815000	usd
CY2021	NXGL	Revenue From Consumer Products RevenueFromConsumerProducts	488000	usd
CY2022	NXGL	Revenue Classified As Others RevenueClassifiedAsOthers	166000	usd
CY2021	NXGL	Revenue Classified As Others RevenueClassifiedAsOthers	102000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2048000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1551000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	723000	usd
CY2022	us-gaap	Depreciation Depreciation	99000	usd
CY2021	us-gaap	Depreciation Depreciation	99000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	207000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	207000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	207000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	263000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	274000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	890000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2048000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	248000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1800000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	246000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	233000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3426690000	shares
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	207000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	295000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	178000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	51000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	88000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	156000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	502000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	291000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	502000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	291000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1315000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1218000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	594000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	495000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	721000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	56000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	54000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	52000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	130000	usd
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	62000	usd
CY2022	NXGL	Unrecognized Share Based Compensation Expense UnrecognizedShareBasedCompensationExpense	116000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	210500	shares
CY2020Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.85938
CY2021	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M14D
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	524937	shares
CY2022	NXGL	Warrant To Purchase Common Stock WarrantToPurchaseCommonStock	3637190	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	90432	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	571429	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	609687	shares
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForExercised	7183	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.7784	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0406	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	39524	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	39524	shares
CY2021	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	2.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	96114	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.61
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	5682	shares
CY2022	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	4.40
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	90432	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.43
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNonvestedNumber	5682	shares
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue	4.40
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	84750	shares
CY2022Q3	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	1.82
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	89000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	285000	usd
CY2021	NXGL	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	5.42717
CY2021	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedContractualTerm	4.98	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3637190	shares
CY2021Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	5.16281
CY2022	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y7M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3637190	shares
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	5.16281
CY2022	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1	P3Y7M24D
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	3637190	shares
CY2022Q4	NXGL	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	5.16281
CY2022	NXGL	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M24D
CY2022Q4	NXGL	Class Of Warrant Or Right Outstanding Intrinsic Value ClassOfWarrantOrRightOutstandingIntrinsicValue	114000	usd
CY2021Q4	NXGL	Class Of Warrant Or Right Outstanding Intrinsic Value ClassOfWarrantOrRightOutstandingIntrinsicValue	372000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	283000	usd
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	276000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	256000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	283000	usd
CY2022Q3	NXGL	Warrant Modification Expense WarrantModificationExpense	57000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	501000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.053	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.053	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.097	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.105	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.006	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.166	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.164	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4112000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3326000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4118000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3330000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4118000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3330000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	15600000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12600000	usd

Files In Submission

Name	View Source	Status
nxgl-20221231_def.xml	Edgar Link	unprocessable
nxgl-20221231_cal.xml	Edgar Link	unprocessable
0001493152-23-009190-index-headers.html	Edgar Link	pending
0001493152-23-009190-index.html	Edgar Link	pending
0001493152-23-009190.txt	Edgar Link	pending
0001493152-23-009190-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nxgl-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
nxgl-20221231_lab.xml	Edgar Link	unprocessable
nxgl-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NXGL
NEXGEL, INC. Stock $nxgl

2023 Q1 Form 10-K Financial Statement

#000149315223009190 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXGL NEXGEL, INC. Stock $nxgl

2023 Q1 Form 10-K Financial Statement

#000149315223009190 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NXGL
NEXGEL, INC. Stock $nxgl